thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
Follow US
© thenewsfacts : All Rights Reserved.

Home » IvyCap New INR 1608Cr Fund to Benefit Series A firms in a Big Way

Business

IvyCap New INR 1608Cr Fund to Benefit Series A firms in a Big Way

TheNewsFacts
Last updated: February 24, 2022 12:10 pm
TheNewsFacts
Share
IvyCap New INR 1608Cr Fund to Benefit Series A firms in a Big Way
SHARE

IvyCap Venture capital fund currently manages assets worth $425 million (Rs 3,200 crore) has declared the first close of its Fund 3 at $214 million (Rs 1,608 crore). Two-thirds of Fund 3 has been secured from its existing investors, a few fresh institutional investors including banks, insurance companies and government departments have also participated. In addition, for the first time, IvyCap has also raised its capital from many family offices.

“The fund is targeting to do its final close at Rs 2,000 crore. However, looking at the demand and the fund strategy, it may increase the size to Rs 2,500 crore,” the IvyCap Ventures said in a statement.

IvyCap currently manages a portfolio of over 30 companies and has already made exits in six companies, including a partial exit in Purplle last year where its Fund 1 saw a 22x cash return for its investment.

Started by Vikram Gupta in 2011, IvyCap built a venture capital model around the global IIT Alumni ecosystem. The company has created a mentoring model through Alumni mentors. Today IvyCap has over 65 core mentors with an additional 5,000 alumni in its inner circle of support. With every exit, the mentor trust receives a payout.

IvyCap targets to invest in 30 Series A Companies

With its Fund 3, IvyCap will continue to focus on areas like consumertech, deeptech, healthtech, fintech, SaaS, and edtech. The fund will deploy an average of Rs 30-40 crore in 20-30 new Series A companies. In addition, the fund will reserve around 20 percent of the corpus for co-investing in its existing portfolio from Fund 2.

“We had conceptualised the Endowment Fund model through integration with an Alumni focused Venture Capital Fund in 2011. Our efforts led to the formation of India’s first Endowment Fund at IIT Delhi that was launched by the Honourable President of India in October 2019. This model was then replicated by IIM Ahmedabad and a few other IITs,” said Vikram. “Today we see a substantial alumni base of 500,000 from IITs and IIMs working very passionately with us.”

The VC firm launched Fund 1 with $40 million in 2014 and used it to invest in 10 companies, while Fund 2 of $80 million was launched in 2020 and invested in 23 companies.

Some of the companies in the portfolio are Purplle, Clovia, BlueStone, Biryani by Kilo, Convosight, Miko, Elucidata, ftcash, and others. The company’s recent exits include Purplle, Pharmarack, and Leixir. Recent investments in portfolio companies Miko and Biryani By Kilo have been made from Fund 3.

TAGGED: IvyCap Fund 3, IvyCap Raises Rs 1608Cr, IvyCap Ventures New Fund, Series A Funding News
Share This Article
Twitter Email Copy Link Print
Previous Article Valimai First Day First Show Review - Ajith Thrills Trends on Social Media Valimai First Day First Show Review – Ajith Thrills Trends on Social Media
Next Article The Wire Slapped Rs 100Cr Defamation Suit by Bharat Biotech The Wire Slapped Rs 100Cr Defamation Suit by Bharat Biotech

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
TwitterFollow
InstagramFollow

Popular Posts

Total Lunar Eclipse 2022: One last time to watch it today, and how

The 2022 total lunar eclipse that will occur today is the last one for the following three…

By TheNewsFacts

From Hope to Risk: AstraZeneca Admits Life Threatening Side Effect of its Covid Vaccine

April 30, 2024: AstraZeneca, a Covid-19 vaccine producer, whose Covid19 vaccine was administered to millions…

By TheNewsFacts

Monkeypox Do you need to be worried? How to prevent it?

In 2018, the UK saw its first incidence of monkeypox. Since then, the health authorities…

By TheNewsFacts

You Might Also Like

Blip
Business

Cash Crunch Blows Death Knell to Blip’s Fast Fashion Dream

By TheNewsFacts
Jane Street
Business

SEBI Drops Hammer on Jane Street: $566M in Illegal Gains

By NewsFacts Bureau
AM Green Group, Greenko
Business

AM Green Group 17.5% Stake in Greenko to Drive Upstream Integration

By TheNewsFacts
Venture Capital
Business

Venture Capital Investment Outlook Still Cloudy for 2025 in Startups

By NewsFacts Bureau
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?